Company intelligence / Profile preview

TZF Polfa

Warsaw, Masovian, Poland

Ownership: Private
Employees: ~900
Development stage: Other

Overview

TZF Polfa, officially Tarchomińskie Zakłady Farmaceutyczne "Polfa" S.A., is a leading Polish pharmaceutical company with a legacy dating back to 1823. Based in Warsaw, the company is one of the largest producers of antibiotics in Central and Eastern Europe, specializing in penicillins and cephalosporins. TZF Polfa is also a critical manufacturer of human insulin and a wide array of psychotropic and dermatological medications. The company operates state-of-the-art production lines that meet international GMP standards and provides comprehensive CDMO services. As a state-owned entity, it plays a vital role in ensuring the drug security of the Polish healthcare system.

Therapeutic areas: PsychiatryEndocrinologyNeurologyInfectious Diseases
Modalities: Small moleculeHormonePeptides
Industry: Biotech

Beyond the preview

Go deeper on TZF Polfa.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TZF Polfa.

Explore the full profile